Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 100 | -41 | -53 | -41 | -990 |
| Depreciation Amortization | 0 | N/A | N/A | N/A | 160 |
| Other Working Capital | 190 | -137 | -77 | -59 | -1,080 |
| Other Operating Activity | -140 | -10 | -11 | 17 | 510 |
| Operating Cash Flow | $150 | $-189 | $-141 | $-83 | $-1,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -156 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | 35 | 35 | N/A | -20 |
| Other Investing Activity | 226 | 161 | 131 | 51 | 550 |
| Investing Cash Flow | $70 | $196 | $166 | $51 | $530 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -35 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 5 | -35 | 0 | 0 | -6 |
| Financing Cash Flow | $-30 | $-35 | $N/A | $N/A | $-6 |
| Beginning Cash Position | 400 | 408 | 408 | 408 | 1,280 |
| End Cash Position | 390 | 380 | 432 | 376 | 400 |
| Net Cash Flow | $-10 | $-28 | $25 | $-32 | $-880 |
| Free Cash Flow | |||||
| Operating Cash Flow | 150 | -189 | -141 | -83 | -1,400 |
| Free Cash Flow | 150 | -189 | -141 | -83 | -1,400 |